Some studies have shown that a high expression of GPX3 can inhibit the development of malignant tumours such as gastric cancer and endometrial cancer, but for ovarian cancer, on the contrary, a high expression of GPX3 promotes the progression and recurrence of ovarian cancer and reduces the survival rate of patients [126,127]. Here, GPX3 is linked to ovarian carcinoma.